絞り込み

16533

広告

Adjunctive Use of a Standardized Extract of Withania somnifera (Ashwagandha) to Treat Symptom Exacerbation in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study.

著者 Chengappa KNR , Brar JS , Gannon JM , Schlicht PJ
J Clin Psychiatry.2018 Jul 10 ; 79(5):.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (16view , 0users)

Medical

Miscellaneous

To determine if adjunctive treatment with a standardized extract of Withania somnifera (WSE), with known anti-inflammatory and immunomodulating properties, improves psychopathology and stress in patients with schizophrenia or schizoaffective disorder (DSM-IV-TR).
PMID: 29995356 [PubMed - in process]
印刷用ページを開く Endnote用テキストダウンロード